We are live on ! Find out more
PSTV

Plus Therapeutics
PSTV

Delisted

PSTV was delisted on the 31st of July, 2026.

Back to rankings

5 hedge funds and large institutions have $11.1M invested in Plus Therapeutics in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more funds holding

Funds holding: 4 → 5 (+1)

73% less capital invested

Capital invested by funds: $41.4M → $11.1M (-$30.3M)

91% less call options, than puts

Call options by funds: $8K | Put options by funds: $85K

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
$8K
Puts
$85K
Net Calls
-$77K
Net Calls Change
+$320K

Top Buyers

Rank Fund Capital Flow
1
GCM
Goldman Capital Management
New York
+$4.54M

Top Sellers

Rank Fund Capital Flow
1
RCM
Rotella Capital Management
Washington
-$151K
2
TC
TFS Capital
Pennsylvania
-$51K
3
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$35K
4
Prudential Financial
Prudential Financial
New Jersey
-$27K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$26K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$57K – – –
Charles Schwab
27
Charles Schwab
California
$53K – – –
T. Rowe Price Associates
28
T. Rowe Price Associates
Maryland
$45K – – –
RhumbLine Advisers
29
RhumbLine Advisers
Massachusetts
$43K – – –
Janney Montgomery Scott
30
Janney Montgomery Scott
Pennsylvania
$41.8K – – –
GS
31
Gagnon Securities
New York
$38K – – –
AIG
32
American International Group
New York
$37.1K – – –
NFG
33
Noven Financial Group
Colorado
$36K – – –
NFA
34
Nationwide Fund Advisors
Ohio
$35K – – –
BA
35
BlackRock Advisors
Delaware
$33K – – –
State Board of Administration of Florida Retirement System
36
State Board of Administration of Florida Retirement System
Florida
$30K – – –
OC
37
Oppenheimer & Co
New York
$29K – – –
Two Sigma Investments
38
Two Sigma Investments
New York
$29K – – –
AC
39
Amici Capital
New York
$27K – – –
FCI
40
Financial Counselors Inc
Kansas
$27K – – –
TRCT
41
Tower Research Capital (TRC)
New York
$25K – – –
Commonwealth Equity Services
42
Commonwealth Equity Services
Massachusetts
$22K – – –
AllianceBernstein
43
AllianceBernstein
Tennessee
$18K – – –
ProShare Advisors
44
ProShare Advisors
Maryland
$18K – – –
DD
45
Dominick & Dominick
New York
$16K – – –
Morgan Stanley
46
Morgan Stanley
New York
$16K – – –
First Manhattan
47
First Manhattan
New York
$15K – – –
Goldman Sachs
48
Goldman Sachs
New York
$15K – – –
CS
49
Credit Suisse
Switzerland
$14K – – –
LI
50
LMCG Investments
Massachusetts
$14K – – –
1
2
3 4

PSTV Hedge Fund Activity: Q3 2014 in Review

5 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q3 2014, worth a combined $11.1M — down 73% from $41.4M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new PSTV positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Goldman Capital Management, opening a new position worth an estimated $4.54M. The largest seller was Rotella Capital Management, cutting an estimated $151K.

  • 5 institutional investors held Plus Therapeutics (PSTV) as of Q3 2014, up from 4 in Q2 2014.
  • Funds reported $11.1M of Plus Therapeutics stock for Q3 2014, down 73% quarter-over-quarter.
  • 1 fund opened new Plus Therapeutics positions in Q3 2014 and 0 closed out, a net change of +1 holder.
  • The largest Plus Therapeutics buyer in Q3 2014 was Goldman Capital Management, an estimated $4.54M added.
  • The largest Plus Therapeutics seller in Q3 2014 was Rotella Capital Management, an estimated $151K sold.

Based on aggregated 13F filings for Q3 2014.